MYC and breast cancer: Two well-known breast cancer driver genomic abnormalities, TP53 mutation and MYC amplification, which are typically seen in high grade IDC, are seen in a much lower incidence in ILC than in IDC, with a pattern similar to the low to intermediate grade IDC [12].